Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH
CARICH
A Randomised Trial to Establish the Efficacy and Safety of Decompressive Craniectomy Combined With Hematoma Removal in Patients With Intracerebral Hemorrhage
1 other identifier
interventional
200
1 country
1
Brief Summary
Decompressive craniectomy has been reported for the treatment of patients with intracerebral hemorrhage. But no prospective randomised controlled trials have yet been undertaken to confirm its effect.The purpose of the study is to determine whether decompressive craniectomy post hematoma removal surgery after intracerebral hemorrhage will reduce the chances of a person dying or surviving with a long term disability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2014
CompletedFirst Posted
Study publicly available on registry
May 12, 2014
CompletedStudy Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedFebruary 5, 2016
February 1, 2016
3 years
May 7, 2014
February 4, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality and disability
according to a 3-6 scores on the modified Rankin Score
3 months
Secondary Outcomes (1)
Occurrence of second Surgery
72 hours
Study Arms (2)
Decompressive Craniectomy
EXPERIMENTALDecompressive Craniectomy afte Hematoma Removal in Patients with Intracerebral Hemorrhage
non-Decompressive Craniectomy
ACTIVE COMPARATORnon-Decompressive Craniectomy afte Hematoma Removal in Patients with Intracerebral Hemorrhage
Interventions
A portion of frontal,temporal, and parietal bone was removed by craniectomy and the size of decompression was about 10x12 cm2.Intracerebral hematoma was evacuated by transcortical approach with the aid of a surgical microscope.
a simple hematoma removal by osteoplastic craniotomy group (HR) or Intracerebral hematoma was evacuated by transcortical approach with the aid of a surgical neuroendoscopyand the size of decompression was about 3x2.5 cm2.
Eligibility Criteria
You may qualify if:
- Evidence of a spontaneous lobar and basal ganglia ICH on CT scan
- Patient within 72 hours of ictus
- Best score on the GCS of 5-13.
- Volume of hematoma between 30 and 100ml \[Calculated using (a x b x c)/2 method\]
- The history of hypertensive
You may not qualify if:
- Clear evidence that the hemorrhage is due to an aneurysm or angiographically proven arteriovenous malformation.
- Intraventricular hemorrhage of any sort
- ICH secondary to tumour or trauma.
- If the hematological effects of any previous anticoagulants are not completely reversed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurosurgery , Southwest Hospital, Third Military Medical University,
Chongqing, China
Related Publications (2)
Zhang C, Zhang S, Yin Y, Wang L, Li L, Lan C, Shi J, Jiang Z, Ge H, Li X, Ao Z, Hu S, Chen J, Feng H, Hu R. Clot removAl with or without decompRessive craniectomy under ICP monitoring for supratentorial IntraCerebral Hemorrhage (CARICH): a randomized controlled trial. Int J Surg. 2024 Aug 1;110(8):4804-4809. doi: 10.1097/JS9.0000000000001466.
PMID: 38640513DERIVEDHu R, Zhang C, Xia J, Ge H, Zhong J, Fang X, Zou Y, Lan C, Li L, Feng H. Long-term Outcomes and Risk Factors Related to Hydrocephalus After Intracerebral Hemorrhage. Transl Stroke Res. 2021 Feb;12(1):31-38. doi: 10.1007/s12975-020-00823-y. Epub 2020 Jun 8.
PMID: 32514905DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rong Hu, MD,PhD
Department of Neurosurgery, Southwest Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 7, 2014
First Posted
May 12, 2014
Study Start
October 1, 2014
Primary Completion
October 1, 2017
Study Completion
October 1, 2018
Last Updated
February 5, 2016
Record last verified: 2016-02